Author: phytonix

Phytonix Sponsors 14th Carbon Dioxide Utilization Summit Dusseldorf, Germany Oct. 2019

The 14th Carbon Dioxide Utilization Summit will be held in Dusseldorf, Germany on October 9th & 10th, 2019. During this new European edition of the event, the conference will explore the current state of the industry, including the effect of new policies and sustainability targets, whilst also exploring the latest tech developments. CEO Bruce Dannenberg will be speaking on Bio-conversion of CO2 -Current Status and Potential.  Phytonix will be a key sponsor of the event.

For more info on the conference visit the link below.

https://www.wplgroup.com/aci/event/co2/

Phytonix Gold Sponsor at 7th Conference on Carbon Dioxide as Feedstock for Fuels, Chemistry, and Polymers-Cologne Germany-March 20-21, 2019

During the 7th Conference on Carbon Dioxide as a Feedstocck, leading players showcased enhanced and new applications using CO2 as feedstock. The main topics of the conference are the new political framework, renewable energy and hydrogen production, artificial photosynthesis, carbon capture technologies as well as CO2-based fuels for transport and aviation, chemicals and polymers as well as mineralisation and proteins.

Bruce Dannenberg, CEO and President, moderated for the CO2 for Chemicals and Materials session and was a speaker for the CO2 for Fuels session. Phytonix served as a gold sponsor of the event.

For more information on the conference, visit the link below.

https://www.biobasedpress.eu/event/7th-conference-on-carbon-dioxide-as-feedstock-for-fuels-chemistry-and-polymers/

Press Release 2019

/20190718005748/en/Phytonix-Corporation-Unleashes-New-Carbon-Dioxide-Utilization

 

Phytonix Corporation

Phytonix Corporation unleashes a new carbon dioxide utilization (CDU) technology to combat climate change.

PRESS RELEASE

For Immediate Release

For more information contact:                                                                                          Brooklin Lyle, Marketing Manager                                              Blyle@phytonix.com  or

Bruce Dannenberg, CEO                                                                                                       Bruce@phytonix.com

Black Mountain, NC June 2019- Phytonix Corporation (Px) is proud to announce its recent success in developing breakthrough technologies to reduce harmful industrial emissions.  Px scientists have engineered new strains of cyanobacteria which use photosynthesis to convert CO2 into carbon negative industrial chemicals and fuels, such as butanol, pentanol and other higher alcohols. Beneficial oxygen is released in the process. Scientists working with Phytonix have recently noted that they have achieved the highest photosynthetic butanol production ever recorded at laboratory scale.

“The climate crisis is an epic battle to preserve Earth and its environment. This cries for a global mobilization and response,” says Bruce Dannenberg, CEO. “Our company has created a gigaton magnitude weapon against climate change capable of removing, via photosynthetic conversion to chemicals and fuels, billions of tonnes of carbon dioxide from our atmosphere annually. A massive global funding initiative must be established to develop and deploy the powerful carbon dioxide utilization (CDU) technologies that will mitigate climate change and stabilize and heal our environment.”

Phytonix is headquartered in North Carolina, USA, with a corporate office in Vancouver, Canada, plus development laboratories and partners in Sweden, Germany, the United States, Nova Scotia and British Columbia, Canada, and The Netherlands. Phytonix Canada Corporation is a wholly owned subsidiary of Phytonix Corporation.

The firm is currently testing and optimizing its full production process at indoor pilot scale and will soon achieve outdoor pilot scale deployment, both in Europe and the USA, with two multinational industrial corporate partners.

The Phytonix process directly reduces greenhouse gas (GHG) emissions at the rate of one metric tonne of CO2 per 138 gallons of biobutanol produced. This significantly carbon negative process is expected to produce cost leadership industrial chemicals at less than half the cost of the incumbent fossil producers. Full global deployment could significantly reduce annual carbon dioxide emissions, slow climate change to manageable levels, and win the fight to save Earth!

Phytonix in Genome BC Press Release

“About Phytonix Corporation:
Phytonix Corporation is an industrial biotechnology company producing sustainable chemicals directly from carbon dioxide. Their patented process employs cyanobacteria, which are the same ancient, photosynthetic organisms responsible for creating a breathable atmosphere on Earth and that contributed greatly to the genesis of our miraculous blue planet. Phytonix’s objective is to be the global leader in bio-safe, direct solar chemical production utilizing carbon dioxide as the sole feedstock for the cyanobacteria along with energy from the Sun. Phytonix and its partners utilize a collaborative business model via a capital-light strategy, based upon circular economy principles, to produce a variety of cost-leadership renewable chemicals and fuels from carbon dioxide, sunlight, and water via patented photobiological and genomics technology.”

https://www.genomebc.ca/blog/converting-waste-gas-into-high-value-flavours-and-fragrances

New Biotech Initiative Proposes to Turn Waste Gas in to Specialty Chemicals

Following the Genome BC Press Release, Phytonix was noticed by Design.com for upcoming opportunites in the cosmetics feild and aligning with the CleanBC Initiative. “The non-profit Genome British Columbia and Phytonix Corporation announced a partnership this month that will result in a manufacturing platform where CO2 emissions from industrial facilities will be converted into specialty chemicals for use in the fragrance industry.

Silhouette of the Power plant in Kiev.

Phytonix featured in Synbiobeta Article

 

 

Technology is ready to confront climate change — are we?

CEO and President, Bruce Dannenberg spoke with Synbiobeta on today’s technology for combatting climate change. “We are currently working collaboratively with two multi-national corporate strategic partners (a large power utility and energy company based in Europe and a large industrial manufacturing company based in the southeastern USA) to deploy our carbon dioxide utilization (CDU) technology to capture their waste CO2 emissions and convert them to low cost solar chemicals and fuels. These would initially be pilot scale installations with rapid expansion to commercial scale. We expect initial outdoor pilot scale deployment in 2020.”

Phytonix Corporation Featured in Industrial Biorenewables: A Practical Viewpoint

Phytonix Corporation’s Founder and CEO, Bruce Dannenberg, is the lead author for Chapter 21 “Phytonix: Cyanobacteria for Biobased Production Using CO2”.

The following is an overview of what the chapter entails.

Phytonix’s photobiological process uses carbon dioxide as the sole, nonbiomass feedstock and along with solar energy and water produces the desired biofuel/chemical with only oxygen and residual biomass as by‐products. The Phytonix technology/IP essentially takes the key genetic code/genes for a butanol synthesis pathway from nonphotosynthetic organisms and engineers them into the genome of a photosynthetic cyanobacteria. Thus, this enables butanol to be generated via a photosynthetic/photobiological engine, using carbon dioxide as the sole feedstock/carbon source. The Phytonix photosynthetic process takes place in cyanobacteria as aquatic‐based photosynthetic microorganism. Phytonix’s full production process requires both an organism as well as the equipment to grow the organisms for the direct secretion of liquid n‐butanol into the culture media and a back‐end process for the separation of the butanol from the water‐based culture solution. Butanol is a valuable industrial chemical with a wholesale global market size of ten billion dollars.

Phytonix’s CEO made a Keynote Presentation at the International Conference on Synthetic Biology- Paris, France- July 16-17, 2018

The International Conference on Synthetic Biology hosted by Meetings International was held in Paris, France this July for leaders within the Synthetic Biology field to gather and discuss the latest developments with upcoming technologies.

Bruce Dannenberg, President and CEO of Phytonix, accepted an invitation and made a keynote presentation on the current and upcoming advancements in the technologies of Phytonix Corporation.

To learn more about this conference click the link below.

https://www.meetingsint.com/conferences/syntheticbiology